TAG:

pathology reimbursement

Using Performance-Based Part A Hospital Path Contracts

CEO Summary: One of pathology’s greatest challenges is adequate reimbursement for hospital Part A Pathology Services. Over the past two decades, ever more hospitals took steps to reduce or eliminate payment to pathologists for these services. Now several innovative pathology gr…

Read More



Revamped Houston JV Validates Industry Trend

CEO SUMMARY: Change is notoriously slow in both the hospital and the clinical laboratory industry. The announcement of a revamped laboratory joint venture between Houston’s Memorial Hermann Healthcare System and Dynacare demonstrates that market pressures continue to encourage the ratio…

Read More



Path Income Strategies Subject Of Symposium

CEO SUMMARY: Public discussion of pathology income and compensation has been taboo for a good reason: the reality is one of contract cutbacks and declining reimbursement for pathology services. THE DARK REPORT is inviting a select group of astute pathologists to Scottsdale on November 8 t…

Read More



AmeriPath Stock Offering Pulled By Underwriters

CEO SUMMARY: Ameripath planned to go public in March. However, the stock market’s significant decline and further evaluation of the company’s business plan caused Wall Street underwriters to defer issuing the stock. Pathologists are curious as to whether AmeriPath’s “employee” b…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.